**6. Conclusions**

As new therapeutic approaches emerge, the treatment of retinal diseases will inevitably continue to shift between medical and surgical interventions. The initiation of various trials facilitates the advancement of retina and enhances patient care. These trials provide opportunities for collaboration among researchers, clinicians, and industry partners, which could lead to the development of more effective treatments and therapies. With the introduction of novel treatments, including several surgical options, there is hope for longer-lasting and even permanent solutions to these challenging conditions.
